Jsf Financial, LLC Eli Lilly & CO Transaction History

Jsf Financial, LLC

$325 Million
Q2 2024

A detailed history of Jsf Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jsf Financial, LLC holds 2,039 shares of LLY stock, worth $1.84 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

2,039

Previous 1,989 2.51%

Holding current value

$1.84 Million

Previous $1.55 Million 19.33%

% of portfolio

0.57%

Previous 0.49%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $36,243 - $45,452	50 Added 2.51%	2,039 $1.85 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $631,877 - $845,362	1,067 Added 115.73%	1,989 $1.55 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $43,590 - $51,387	-83 Reduced 8.26%	922 $537,000
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $39,992 - $55,135	-92 Reduced 8.39%	1,005 $539,000
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $33,320 - $44,553	95 Added 9.48%	1,097 $514,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $19,259 - $22,618	-62 Reduced 5.83%	1,002 $344,000
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $64,631 - $75,308	-201 Reduced 15.89%	1,064 $389,000
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $528,030 - $601,746	-1,781 Reduced 58.47%	1,265 $409,000
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $2,508 - $2,945	-9 Reduced 0.29%	3,046 $988,000
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $44,356 - $55,123	189 Added 6.59%	3,055 $875,000
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $899 - $1,116	4 Added 0.14%	2,866 $792,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $56,286 - $69,268	254 Added 9.74%	2,862 $661,000
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $28,346 - $36,665	157 Added 6.41%	2,608 $599,000
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $57,512 - $74,452	-350 Reduced 12.5%	2,451 $458,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $49,313 - $65,254	378 Added 15.6%	2,801 $473,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $51,761 - $59,872	354 Added 17.11%	2,423 $359,000
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $31,922 - $38,418	234 Added 12.75%	2,069 $340,000
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $218,456 - $270,387	1,835 New	1,835 $255,000

Others Institutions Holding LLY

# of Institutions

3,901

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $859B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jsf Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jsf Financial, LLC with notifications on news.

Account

Jsf Financial, LLC Eli Lilly & CO Transaction History